Grivas, A A <br/><br/>
Implication of bevacizumab in fatal arterial thromboembolic incidents.  [electronic resource] 

 -  Journal of B.U.ON. : official journal of the Balkan Union of Oncology   
 - 115-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1107-0625 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Angiogenesis Inhibitors--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Anticoagulants--therapeutic use<br/>Bevacizumab<br/>Fatal Outcome<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Maxillary Neoplasms--drug therapy<br/>Middle Aged<br/>Sarcoma--drug therapy<br/>Thromboembolism--chemically induced